Emergent Biosolutions
EBS
EBS
132 hedge funds and large institutions have $570M invested in Emergent Biosolutions in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 49 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.93% more ownership
Funds ownership: 66.34% → 69.27% (+2.9%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
132
Holding in Top 10
1
Calls
$597K
Puts
–
Top Buyers
| 1 | +$5.14M | |
| 2 | +$4.86M | |
| 3 | +$3.06M | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$2.68M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.3M |
Top Sellers
| 1 | -$5.42M | |
| 2 | -$3.2M | |
| 3 | -$1.65M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.16M |
| 5 |
KIA
King Investment Advisors
Houston,
Texas
|
-$1.04M |